国药控股ADR(SHTDY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SHTDY 国药控股ADR

盘后交易 02-27 15:58:05 EST 延时

{"stockData":{"symbol":"SHTDY","market":"US","secType":"STK","nameCN":"国药控股ADR","latestPrice":13.56,"timestamp":1772225885011,"preClose":13.6,"halted":0,"volume":253529,"delay":15,"changeRate":-0.002941176470588173,"floatShares":268330371,"shares":624131238,"eps":1.563169,"marketStatus":"盘后交易","change":-0.04,"latestTime":"02-27 15:58:05 EST 延时","open":13.41,"high":13.56,"low":13.39,"amount":3419757.463000004,"amplitude":0.0125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.563169,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772240400000},"marketStatusCode":4,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":13.6,"volumeRatio":5.755796},"requestUrl":"/m/hq/s/SHTDY","defaultTab":"news","newsList":[{"id":"2593348927","title":"刚刚！国药控股董事长正式官宣","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348927","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593348927?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:39","pubTimestamp":1766381987,"startTime":"0","endTime":"0","summary":"国药控股董事长职位调整尘埃落定。国药控股换帅落定同步更新董事名单12月19日，随着国药控股股东特别大会的召开，国药控股此前提名的国药系老将晋斌正式出任董事长。目前，国药控股最新董事名单已同步更新，具体角色与职能如下：营收承压亟待破局已开启多项合作目前来看，晋斌上任之际，国药控股正面临持续的营收增长压力。强强合作成为国药控股扭转营收颓势的方式之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2589834850","title":"国药控股（湖南）医药创新产业园即将投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834850","media":"红网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589834850?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:49","pubTimestamp":1764838153,"startTime":"0","endTime":"0","summary":"国药控股（湖南）医药创新产业园作为国药控股湖南有限公司布局医药健康供应链的重点项目，国药控股（湖南）医药创新产业园于2024年4月正式开工建设，核心定位为现代化、智慧化医药健康产业供应链枢纽与服务平台，建成后将进一步完善区域医药供应链体系，提升公共卫生应急保障能力。相较于一期项目，国药控股（湖南）医药创新产业园在功能升级、技术应用、服务效能上实现质的飞跃。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2589983486","title":"复宏汉霖重续与国药控股经销协议 年度上限逐年递增","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983486","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589983486?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:03","pubTimestamp":1764813828,"startTime":"0","endTime":"0","summary":"12月3日，复宏汉霖（02696）发布公告，宣布与国药控股的经销框架协议（2025重续）已达成，该协议的初始期限自2023年1月1日起至2025年12月31日止，现已自动续期三年，新的协议有效期自2026年1月1日至2028年12月31日。根据协议，复宏汉霖将继续向国药控股集团销售其产品，预计在2026年、2027年及2028年，每年的交易金额上限分别为38.7亿元、39.01亿元及44.53亿元。过去的交易金额显示，2023年和2024年期间，复宏汉霖自国药控股收到的销售收入分别约为19.17亿元及20.41亿元，而截至2025年9月30日的九个月内，销售金额约为16.93亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204100744a4cb8520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204100744a4cb8520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2582375132","title":"美国OTC市场国药控股盘中异动 股价大涨5.44%报13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582375132?lang=zh_cn&edition=full","pubTime":"2025-11-11 23:34","pubTimestamp":1762875294,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时34分，美国OTC市场国药控股股票出现异动，股价急速上涨5.44%。美国OTC市场国药控股股票所在的医疗销售行业中，整体跌幅为0.43%。美国OTC市场国药控股公司简介：国药控股股份有限公司成立于2003年，是中国最大的药品和医疗器械批发商和零售商，2009年在香港联交所上市。截至2024年底，国药控股最大的业务部门是药品分销，占其总收入的70%以上。目前，医疗器械分销占国药控股总收入的20%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233454a6f25546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233454a6f25546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2565330742","title":"国药控股相关公司新增一项122.34万元的招标项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2565330742","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565330742?lang=zh_cn&edition=full","pubTime":"2025-09-04 23:50","pubTimestamp":1757001000,"startTime":"0","endTime":"0","summary":"（来源：快查一企业中标了）快查APP显示，国药控股相关公司国药控股菱商医院管理服务(上海)有限公司于2025年9月4日发布一则招标信息，项目名称为国药控股菱商医院管理服务(上海)有限公司医院智能管理设备租赁服务项目招标公告，预算金额为122.34万元。快查股权穿透数据显示，该公司由国药控股持股，出资比例为60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423572497780183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423572497780183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","SHTDY","BK1500","LU0640798160.USD","01099","BK1197","BK1515"],"gpt_icon":0},{"id":"2565258078","title":"国药控股天和吉林医药有限公司中标吉林大学第二医院激光光学系统采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2565258078","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565258078?lang=zh_cn&edition=full","pubTime":"2025-09-04 13:25","pubTimestamp":1756963503,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年9月3日，吉林大学第二医院激光光学系统采购项目公布中标结果。中标供应商为国药控股天和吉林医药有限公司，中标金额为35万元。采购人吉林大学第二医院位于吉林省长春市，本次采购项目内容为激光光学系统设备的采购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090413264195128626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090413264195128626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0262},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0932},{"period":"6month","weight":-0.1824},{"period":"1year","weight":-0.3105},{"period":"ytd","weight":-0.1947}],"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","exchange":"PINK LIMITED","name":"国药控股ADR","nameEN":"Sinopharm Group Co. Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股ADR(SHTDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股ADR(SHTDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股ADR,SHTDY,国药控股ADR股票,国药控股ADR股票老虎,国药控股ADR股票老虎国际,国药控股ADR行情,国药控股ADR股票行情,国药控股ADR股价,国药控股ADR股市,国药控股ADR股票价格,国药控股ADR股票交易,国药控股ADR股票购买,国药控股ADR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股ADR(SHTDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股ADR(SHTDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}